Vesugen

Vesugen is a peptide bioregulator derived from blood vessel tissue, studied for its effects on vascular health signalling and endothelial cell function. As a tissue-specific peptide complex, Vesugen's mechanism centres on modulating the metabolic activity of vascular tissue — particularly the endothelial cells that line the interior surface of blood vessels and the smooth muscle cells that comprise the vessel wall. The endothelium is a critical signalling organ: endothelial cells produce nitric oxide (NO) via endothelial nitric oxide synthase (eNOS), regulate vascular tone, control vascular permeability, and modulate platelet aggregation and leukocyte adhesion. Vesugen is studied for its potential to upregulate endothelial function pathways that support vascular homeostasis, including the PI3K/Akt/eNOS pathway for nitric oxide production and the VEGF pathway for vascular maintenance and repair. The peptide complex may also modulate the balance between factors that promote vascular health (NO, prostacyclin) and those that promote vascular pathology (endothelin-1, inflammatory cytokines), making it relevant to research on vascular ageing, endothelial dysfunction, and vascular tissue regeneration.